The upcoming rollout of Covid-19 vaccines here will accelerate the rebound of small- and mid -cap stocks (SMC) and they are expected to catch up with larger caps on attractive valuations, says DBS Group Research analyst Ling Lee Keng in a Jan 5 note.  The hospitality and retail sectors, in part...

CGS-CIMB analyst William Tng says he is “positive” on the outlook for the tech sector in 2021. This, he says, is due to the acceleration of digitalisation of many work processes during the Covid-19 pandemic, which has led to higher demand for IT-related infrastructure. “At the same time, there...

RHB analyst Jarick Seet has maintained his “buy” call on Frencken Group with a higher target price of $1.37 from $1.22 previously. This comes after the group announced, on Dec 21, that it would take an impairment loss of $6.2 million that’s associated with the development of a product in the h...

FRENCKEN Group's recognition of an impairment loss of S$6.2 million for fiscal 2020 will not affect the outlook of Maybank Kim Eng and CGS-CIMB, their research teams said in separate reports on Tuesday.

FRENCKEN Group's recognition of an impairment loss of S$6.2 million for fiscal 2020 will not affect the outlook of Maybank Kim Eng and CGS-CIMB, their research teams said in separate reports on Tuesday.

UOB Kay Hian analyst John Cheong and the Singapore research team have highlighted BRC Asia, Food Empire, Frencken and InnoTek as its top buy picks among the small-mid cap sector. He has given all three “buy” calls with target prices of $1.88, 88 cents and 82 cents respectively. The brokerage has...

Maybank Kim Eng analyst Lai Gene Lih is recommending Hi-P International’s investors to accept the $2 per share privatisation offer tabled on Dec 18 by chairman Yao Hsiao Tung. The offer price is 10.5% above Hi-P’s last traded price of $1.81 before the offer was announced on Friday morning. The $...

Just eight years ago, a company serving the semiconductor industry was teetering on the brink of bankruptcy. It was losing its investors and was on the Singapore Exchange (SGX) Watchlist, set to be delisted if it could not meet requirements such as the minimum market capitalisation, or earnings. Fas...

Analysts are recommending ‘buy’ on global technology company Frencken Group for its proxy to growth trends in 5G, AI, health and wellness and population aging through its blue-chip custoemrs, says Maybank Kim Eng analyst Lai Gene Lih. This comes on the back of 3QFY2020 earnings of $13.3 million....

Frencken Group’s better-than-expected results in 3Q have led analysts to be more optimistic of the company’s prospects ahead. CGS-CIMB Research has raised its target price to $1.27 from $1.25 previously. Maybank Kim Eng, too, has increased its target price to $1.39 from $1.33 previously. DBS Gro...